Studies explore pharmacological approaches to cataract prophylaxis, treatment
Investigators find options could prove to be alternatives to surgical management.
Iris-fixated IOLs are a boon for treating high myopia
Phakic lenses are proving to be excellent additions to refractive practices.
Raising the bar for premium pterygium procedure
Physician pioneers technique offering higher perspective in surgery, outcomes.
Challenges to topical drop adherence after cataract surgery
With intraoperative sustained release steroids, ophthalmologists can eliminate the gambles of patient adherence.
Zeroing in on dry eye treatment for patients with cataracts
Study supports preoperative ocular surface optimization with artificial tears.
Eliminating preop fasting leads to happier cataract patients
Change can prove to benefit individuals with diabetes, other comorbidities.
Haptic flanging reduces IOL dislocations after cataract surgery
Procedure increases lens stability and improves visual acuity in patients.
Visual outcomes of small-aperture IOL implant in post-laser refractive eyes
Robert Ang, MD, discusses highlights of his AAO 2020 presentation on a study analyzing the vIsual outcomes of a small-aperture IOL implantation in patients with a history of post-laser refractive surgery.
Celebrating a pivotal moment in laser-vision correction history
Advances in laser-vision correction provide visual results that often surpass 20/20.
Antibiotic-steroid combination boosts confidence with delivery
AAO live: Drop-free prophylaxis regimen before cataract surgery lowers treatment burden with caveats
Speaking during the American Academy of Ophthalmology’s virtual 2020 annual meeting, Neal H. Shorstein, MD, explained how physicians at Kaiser Permanente have been using a prophylactic drop-free drug regimen before cataract surgery for more than a decade. Their regimen is so streamlined that the only drop that patients receive in anticipation of cataract surgery is a supplemental dilation drop instilled preoperatively while they are still in the holding area.
Pre-operative IOP hints after cataract surgery
Elevated pressure can lead to irreversible optic nerve damage, vision loss
Small-aperture single-piece IOL could fill unmet need in patients
Optics block out-of-focus and stray light, allow continuum of vision.
Long-acting prostaglandin implant creating shift in IOP-lowering therapy
Sustained release helps mitigate disease progression without impacting quality of life.
Minimize inflammation after cataract surgery
Large randomized trial compares efficacy and safety of multiple regimens
Improve patient comfort with intravitreal injections
Study points to possible role of addressing preprocedural anxiety
Examining ocular allergy, quality of life
Surveyed patients express dissatisfaction with efficacy of eye drops.
Research: Similar endophthalmitis rates for generic, branded topical antibiotics
A number of options may offer major cost savings, positive results for patients.
Dispelling myths about refractive lens exchange
RLE, in unexpected twist, is gaining support among surgeons
Perioperative medications can eliminate postoperative drops after cataract surgery
Options can reduce the treatment burden for patients, leading to improved outcomes
Macular OCT imaging is vital in work-up of cataract surgery patients
Investigators find value in screening for macular disease in preoperative evaluation
Dropless, hands-free regimen key for patients
Following cataract surgery, the dropless option is proving to be a preferred method during recovery
Image quality or depth of field — or both?
ICYMI: Alice Epitropoulos, MD, FACS, speaks on "Image quality or depth of field or both: Clinical outcomes from spherical aberration neutral monofocal toric IOL," during the 2020 ASCRS virtual meeting.
Pass-through provides vehicle to drive innovation
As more novel ophthalmic drugs and devices become available under the
CMS “pass-through”designation, practices should be proactive in embracing these
Surgeons discuss MIPS, impact of pass-through medications
Bonuses are the norm and not risked by pass-through medication use
AAO 2019: Newer options optimize pharmaceutical management for lens surgery patients
According to William D. Trattler, MD, surgeons today can choose from a number of newer modalities that address the drawbacks associated with previous options.
Quieting the neuropathic components of ocular pain
Large population-based study questions value of routine NSAID use after cataract surgery
Novel delivery system shows positive performance in phase II trial
Intracamerally injected mydriatic agents in cataract surgery: Good safety profile
2 Clarke Drive Cranbury, NJ 08512